IN TR ODUC T ION
Clostridium difficile has been isolated in routine microbiology laboratories since it was recognised as a potential pathogen in the late 1970s [1] . Its main virulence factors are two large toxins [toxin A (TcdA) and toxin B (TcdB)], and diagnostic tests rely on culture and/or detection of one or both toxins. In recent years, new features of C. difficile have been discovered, such as variability in toxin A and B production, variability of toxin genes for toxins A and B and production of a third toxin (binary toxin CDT) by certain strains [2, 3] . This paper will describe how these new findings can be used in routine diagnostic procedures.
It has long been accepted that toxigenic strains always produce both toxins A and B and that non-toxigenic strains do not posses toxin genes [4] . However, toxin A-negative, toxin B-positive (A-/Bþ) strains have only been described recently [5] [6] [7] . Such A-/Bþ strains are usually referred to as variant or toxin-variant C. difficile strains. But differences in toxin production is not the only variation among C. difficile isolates. Far greater heterogeneity is observed when toxin genes for toxins A and B are screened. We define toxin-variant strains as those producing only toxin A or B (at present only A-/Bþ toxinvariant strains are known), and variant strains are all the C. difficile strains characterised by changed toxin genes tcdA and tcdB when compared to the reference strain VPI 10463 [8] . Therefore, toxin-variant strains are only one group of variant C. difficile strains.
Changes within toxin genes are deletions, detected only in repetitive regions of the tcdA gene, or restriction site polymorphisms, which are observed in both toxin genes (Table 1) . In terms of toxin production, variant strains can produce both toxins (Aþ/Bþ strains), only TcdB (A-/Bþ strains), or are non-cytotoxic but still possess parts of the toxin genes (A-/Bstrains) (Table 1) [3, 9] . Variant C. difficile strains are grouped into toxinotypes I-XV, whereas strains similar to VPI 10463 belong to toxinotype 0 [8, 9] .
HOW TO DE T EC T C. DIFFICILE VAR I AN T S TR AIN S
Methods for laboratory diagnosis of C. difficile usually depend on isolation of pure culture as well as on detection of toxin production on cultured cells or with commercial immunological tests [1] . Such methods would correctly diagnose the majority of variant strains as C. difficile. However, with classical methods, variant strains (with changes in toxin genes) cannot be distinguished from VPI 10463-like strains ( Table 2 ). If only a commercial toxin A-detecting diagnostic kit is used, strains from toxinotypes VIII and X (producing only toxin B) and toxinotype XI (non-cytotoxic) are not even detected. On the other hand, A-/Bþ strains (toxinotypes VIII and X) are the only variant strains recognised if a combination of cell culture test (with positive result) and immunological test (with negative result) is used ( Table 2) .
Detection of variant strains in the clinical laboratory can be based on differences between variant strains (toxinotypes I-XV) and ordinary (toxinotype 0) strains. As mentioned above, variant strains can differ from ordinary strains in: (i) production of toxins TcdA and TcdB, (ii) toxin genes tcdA and tcdB, and (iii) production of binary toxin (Table 1) .
Relying solely on differences in toxin production, only two toxinotypes (VIII and X), representing A-/Bþ strains, will be recognised. Here we should mention that cell culture tests can be helpful in determining variant strains. It is well known that some C. difficile variant strains (1470, 8864) cause different cytopathic effects when compared with ordinary strains [10] [11] [12] . Usually, cells treated with supernatants containing C. difficile toxins detach, but retain long projections (actinomorphic morphology). Strains from toxinotypes VIII and X (both A-/ Bþ) and IX (Aþ/Bþ) cause cell rounding without projections. Thus, if the cell culture test is read carefully, some groups of variant C. difficile strains can be recognised. It is recommended that each laboratory tests its own cell line with culture supernatants of VPI 10463 and 8864 (type strain for toxinotype X) or 1470 (type strain for toxinotype VIII).
Most of the variant toxinotypes will be recognised if the toxin genes for TcdA and TcdB are screened. There are many PCRs described for amplification of some parts of C. difficile toxin genes and some of them also detect variations, mainly in tcdA [13, 14] . We have described a PCR method for amplification of the entire 19 kb of PaLoc with 10 overlapping PCR fragments [8] , and we have shown that two of those PCR fragments are mostly variable (B1 and A3) and are good markers when searching for variant strains ( Table 1) . The PCR method is described in detail in references [8, 15] and on our toxinotyping home-page (http://www.uni-lj.si/bfbcdiff). One can use only one of the PCRs or both of them. If both PCR fragments are tested, then the tested strain is not only recognised as a variant, but can already be grouped in one of the 15 toxinotypes. With this method, all known and potential new types of variant strains are recognised. The drawback of the method is that it requires long PCR programs of about 6 h and must be combined with restriction analysis. If only one region of the toxin genes for TcdA and TcdB is to be tested, then the most suitable part is the repetitive region of tcdA (amplified in A3 PCR fragment) because this part is changed in most toxinotypes ( Table 1 ). The only exception is toxinotype XII, which has changes only in the tcdB gene. A3 PCR fragment will not be amplified in strain 8864 (toxinotype X) and, if production of toxin B is not tested, this type of strain will not be detected. 
n a n a n a n a Checking only the A3 PCR fragment allows recognition of 13 out of 15 known variant toxinotypes and, although less laborious than amplification of both fragments (B1 and A3), it is still time-consuming.
For screening that is applicable in routine laboratories, a quick and easy method is needed which would still recognise the most important variant toxinotypes, i.e. the detection of binary toxin genes. The majority of strains with changes in genes tcdA and tcdB (variant strains) will produce a binary toxin (Table 1 ) [3] . To date, no strain from toxinotype 0 (VPI 10463-like strains) has been binary toxin-positive. When amplification of binary toxin genes is used as a screening method, 10 out of 15 toxinotypes can be detected (Table 2 ). This method is less effective than amplification of the A3 PCR fragment described above, but is easier and less time-consuming. Toxinotypes not possessing binary toxins (I, II, XII, XIII, VIII) are not significantly changed in their toxin genes or are A-/Bþ strains (Table 1) .
There are two binary toxin genes (cdtA and cdtB) coding for two components of the binary toxin. Variant strains studied to date have both genes but it seems that amplification of cdtB is more efficient [3] . We would suggest PCR amplification of part of the cdtB gene (described in detail on our toxinotyping home page and in reference [3] ) as a method of choice for quick detection of variant C. difficile strains because: (i) it is easy to perform, (ii) it does not include restriction of the amplified fragment and is therefore less time-consuming, and (iii) it would detect the majority of variant strains with significantly changed toxin genes. Still, positive amplification of binary toxin genes only shows that the tested strain is most probably a variant. To assign it to a given toxinotype, toxinotyping (characterisation of B1 and A3 fragments) must be performed.
W H Y I S DE T EC T ION OF C. DIFFICILE VAR I AN T S TR AIN S IMP OR TAN T ?
Based on the studies of two large C. difficile collections [8, 9] , the prevalence of variant strains within the C. difficile population was calculated to be approximately 8%. But the clinical importance of C. difficile variant strains is unknown because they are not recognised as special subgroups of C. difficile. Similarly, the A-/Bþ strains have been largely underestimated because such strains have not been recognised in diagnostic laboratories. Their role in causing severe disease and outbreaks was clarified only recently [17] [18] [19] .
Variant C. difficile strains can be searched for in established strain collections or directly in routine laboratories as a part of C. difficile diagnostics. Strain collections previously typed with one of the molecular typing methods are most suitable, as the presence of variant toxin genes correlates well with molecular typing [9] . With such studies, the overall prevalence of variant strains will be determined and most probably some new types of variant C. difficile strains will be discovered. This is also a way to see if some variant C. difficile strains are more prevalent in certain hosts. In animals, C. difficile can cause intestinal diseases as well, and a high percentage of binary toxin-positive strains (which are most probably variant C. difficile strains) was reported in horses, whereas such strains were not detected in dogs or cats [20] .
Detection of variant strains in routine diagnostic laboratories should provide useful information on the prevalence of different toxinotypes within a given hospital at a given time. Most importantly, this is the only way to find a possible connection between variant strains and special patient populations or forms of the disease because, when a strain is identified as a variant, additional data about the symptoms (which usually are not available for collection strains) can be obtained.
There are several reasons why different toxinotypes can be expected to correlate with different forms of the disease or different populations. One reason is the production of variant toxins with changed properties by variant strains. For some strains, it has already been shown that the toxins they produce differ from VPI 10463 toxins in catalytic properties [12, 21] . Likewise, we can expect variant toxins to differ in translocating or receptor-binding, which can determine host or tissue specificity. The observation that most variant strains produce at least one additional virulence factor not detected in ordinary strains, namely binary toxin [3] , supports the speculation of the clinical importance of variant strains. Typically, in other clostridial species (e.g. C. perfringens and C. novyi), groups of strains produce certain combinations of toxins. These toxin-production types are then predominant in different hosts or in different forms of the disease. To date, C. difficile has been regarded as producer of only two major toxins (TcdA and TcdB). With the identification of binary toxin-producing strains, C. difficile strains can also be distributed into five toxin production types (Table 1) [3] . But the connection between these types and certain diseases remains to be discovered.
Detection of binary toxin genes would not only aid the identification of variant strains but would also help to elucidate the role of some non-toxigenic (A-/B-) strains isolated from symptomatic patients. Strains that do not produce TcdA and TcdB were regarded as non-virulent, but we have shown that some non-cytotoxic strains can produce a binary toxin (toxinotype XI) [3] which could then act as a potential virulence factor.
In this paper, two PCR-based methods are described which can be used not only for recognition of A-/Bþ C. difficile strains but also for detection of variant A-/B-and Aþ/Bþ strains. Information on the prevalence of variant strains and their clinical importance can be obtained using these methods. Screening
